Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 - CAS 1224601-12-0

Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 - CAS 1224601-12-0 Catalog number: BADC-01641

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is a cleavable antibody agent conjugate linker used in the synthesis of antibody-drug conjugates (ADCs).

Category
ADCs Linker
Product Name
Lys(MMT)-PAB-oxydiacetamide-PEG8-N3
CAS
1224601-12-0
Catalog Number
BADC-01641
Molecular Formula
C55H77N7O14
Molecular Weight
1060.24

Ordering Information

Catalog Number Size Price Quantity
BADC-01641 -- $-- Inquiry
Description
Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is a cleavable antibody agent conjugate linker used in the synthesis of antibody-drug conjugates (ADCs).
IUPAC Name
(2S)-2-[[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethoxy]acetyl]amino]-N-[4-(hydroxymethyl)phenyl]-6-[[(4-methoxyphenyl)-diphenylmethyl]amino]hexanamide
Canonical SMILES
COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)NCCCCC(C(=O)NC4=CC=C(C=C4)CO)NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCN=[N+]=[N-]
InChI
InChI=1S/C55H77N7O14/c1-67-50-21-17-48(18-22-50)55(46-10-4-2-5-11-46,47-12-6-3-7-13-47)58-23-9-8-14-51(54(66)60-49-19-15-45(42-63)16-20-49)61-53(65)44-76-43-52(64)57-24-26-68-28-30-70-32-34-72-36-38-74-40-41-75-39-37-73-35-33-71-31-29-69-27-25-59-62-56/h2-7,10-13,15-22,51,58,63H,8-9,14,23-44H2,1H3,(H,57,64)(H,60,66)(H,61,65)/t51-/m0/s1
InChIKey
PKUIBTBLKQVEJS-XHIZWQFQSA-N
Appearance
Off-white to light yellow Oil

Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is a multifunctional compound designed for use in the development of advanced bioconjugation strategies. The compound incorporates several key components: lysine (Lys) as a reactive site, MMT (4-methyltriazolylmethoxy) as a protecting group, PAB (para-aminobenzyl) for linker chemistry, and PEG8 (a polyethylene glycol chain) to enhance solubility and improve pharmacokinetics. The compound also contains an azide group (N3), which enables click chemistry reactions for efficient conjugation to a wide range of biomolecules, such as proteins, peptides, or antibodies. This unique structure makes Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 useful for creating targeted drug delivery systems and developing antibody-drug conjugates (ADCs).

One of the primary applications of Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is in the field of bioconjugation, particularly for the synthesis of antibody-drug conjugates (ADCs). The azide group allows for click chemistry-based attachment of drugs or other therapeutic agents to antibodies or other targeting molecules. The PEG8 spacer provides flexibility and steric shielding, which is crucial for reducing immunogenicity and enhancing the stability of the conjugate. By linking a cytotoxic payload or biologically active agent to the targeting antibody, Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 can facilitate precise drug delivery to specific cells, such as cancer cells, reducing off-target effects and improving treatment efficacy.

Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 also plays a significant role in the development of imaging agents for diagnostic purposes. The azide group is reactive in bioorthogonal reactions, allowing for the conjugation of imaging probes or fluorescent markers to targeting molecules. This enables the visualization of specific cells or tissues in vivo through non-invasive imaging techniques, such as positron emission tomography (PET) or fluorescence imaging. This application is especially valuable for studying disease progression, monitoring the effectiveness of therapies, or guiding surgical resection of tumors.

Another potential application of Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is in the creation of personalized medicine strategies. By using the click chemistry approach, drugs can be conjugated to a patient’s specific biomarkers or therapeutic targets, ensuring that the drug delivery is tailored to individual patients. This strategy can lead to more effective and safer treatments, particularly in oncology, where targeting specific tumor markers is crucial for improving outcomes. The versatility and efficiency of the compound make it a valuable tool in precision medicine and drug development.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Resources & Supports
)
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

x